Resurrect Bio Revenue and Competitors
Estimated Revenue & Valuation
- Resurrect Bio's estimated annual revenue is currently $775k per year.
- Resurrect Bio's estimated revenue per employee is $77,500
Employee Data
- Resurrect Bio has 10 Employees.
- Resurrect Bio grew their employee count by 67% last year.
Resurrect Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder | Reveal Email/Phone |
3 | Senior Scientist | Reveal Email/Phone |
4 | Research Technician | Reveal Email/Phone |
Resurrect Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 16 | 23% | N/A | N/A |
#2 | $11.8M | 76 | 21% | N/A | N/A |
#3 | $1.8M | 23 | 35% | N/A | N/A |
#4 | $2.2M | 29 | 61% | N/A | N/A |
#5 | $1.8M | 23 | 35% | N/A | N/A |
#6 | $0.9M | 12 | 9% | N/A | N/A |
#7 | $0.1M | 1 | 0% | N/A | N/A |
#8 | $18.3M | 118 | -3% | N/A | N/A |
#9 | $0.5M | 6 | 20% | N/A | N/A |
#10 | $4.8M | 62 | 41% | N/A | N/A |
What Is Resurrect Bio?
We are a plant biotech start-up, based in London. We're working on how to improve the immune system of crop species.Crops were bred over generations by plant breeders to improve key traits such as yield, height or drought-tolerance, but sometimes inadvertently lost key immune resistance genes. Additionally, modern monocultures are static in evolution, but the pests and pathogens that threaten them are not. Plant diseases are constantly evolving new ways of defeating the R-genes in crops. Climate change is making matters worse – diseases are spreading to new locations, meaning the disease spectrum farmers are dealing with is expanding.
keywords:N/AN/A
Total Funding
10
Number of Employees
$775k
Revenue (est)
67%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 10 | -37% | N/A |
#2 | $1.3M | 10 | 0% | N/A |
#3 | $0.9M | 10 | 0% | N/A |
#4 | $1.5M | 10 | -9% | N/A |
#5 | $0.9M | 10 | -9% | $8M |